Understanding the genetic factors for Vibrio cholerae virulence
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 473856
Grant search
Key facts
Disease
CholeraStart & end year
2022Known Financial Commitments (USD)
$98,689.66Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Lypaczewski PatrickResearch Location
CanadaLead Research Institution
McGill UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen genomics, mutations and adaptationsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Cholera is an infectious disease caused by the Vibrio cholerae bacteria affecting up to 4 million individuals per year, often following wars or natural disasters in developing countries. With climate change however, the risk of outbreaks in North America and in Europe keeps increasing. While the infection has the potential to be lethal, it can also present itself entirely without symptoms. What determines the progression of this infection (lethal/non-lethal, symptomatic/asymptomatic) is not yet fully known. Our project aims at identifying the factors that contribute to cholera virulence to then be able to predict the outcome of an infection based on these factors. To do so, we will collect hundreds of samples of Vibrio cholerae bacteria, the causative agent of cholera disease from infected patients and family members within the same household. We will then use deep sequencing to obtain and analyze the genomes of the different bacteria present to identify variations between lethal/non-lethal or symptomatic/asymptomatic infections. Finally, using the results of our analysis, we will use Artificial Intelligence to build a predictive model based on the genetic variations and the outcome of the disease we observed to be able to predict the outcome of the disease from future samples.